Quantum Biopharma (QNTM) Change in Inventory (2019 - 2026)
Quantum Biopharma's (QNTM) quarterly Change in Inventory came in at $51468.0 in Q1 2026, up 120.08% year-on-year from $23386.0 in Q1 2025, and up 101.92% quarter-over-quarter from $25489.0 in Q4 2025.
Quantum Biopharma (QNTM) Change in Inventory (2019 - 2026) Analysis & Trends
Quantum Biopharma has disclosed Change in Inventory across 4 years of filings, most recently posting $51468.0 for Q1 2026.
- Change in Inventory for Q1 2026 came in at $51468.0, up 120.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $51468.0 (up 154.84% YoY), and the FY2025 annual result was $52133.0, down 55.53% from the prior year.
- Change in Inventory came in at $51468.0 for Q1 2026 at Quantum Biopharma, up from $25489.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $77622.0 in Q3 2025 to a low of -$117242.0 in Q4 2024.
- The 3-year median for Change in Inventory is $38478.5 (2025), against an average of $22932.0.
- Across the five-year window, Change in Inventory surged 121.74% in 2025 and jumped 120.08% in 2026, its largest moves.
- Quantum Biopharma's Change in Inventory stood at -$117242.0 in 2024, then jumped by 121.74% to $25489.0 in 2025, then jumped by 101.92% to $51468.0 in 2026.
- The last three Change in Inventory figures came in at $51468.0 (Q1 2026), $25489.0 (Q4 2025), and $77622.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -26.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,468.00 |
| Mar 31, 2026 | 51,468.00 |
| Dec 31, 2025 | 25,489.00 |
| Dec 31, 2025 | 25,489.00 |
| Sep 30, 2025 | 77,622.00 |
| Sep 30, 2025 | 77,622.00 |
| Jun 30, 2025 | 76,869.00 |
| Jun 30, 2025 | 76,869.00 |
| Mar 31, 2025 | 23,386.00 |
| Mar 31, 2025 | 23,386.00 |
| Dec 31, 2024 | -117,242.00 |
| Dec 31, 2024 | -117,242.00 |
| Dec 31, 2019 | 714,274.74 |
| Dec 31, 2019 | 714,274.74 |